Early research (Phase 1)Study completedNCT00074646
What this trial is testing
Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas
Who this might be right for
GlioblastomaMalignant Gliomas
Celgene Corporation 36